CLDX
Celldex Therapeutics, Inc.Company with tickers: CLDX
CIK
744218
CUSIP
15117B202
Shares Outstanding
78,492,072
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $15,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $73,001,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-84,435,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-78,685,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.18 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |